Physician profile
Hunter Aronson
NPI 1174186969
$9,617.39
in general payments reported to CMS, 2019-2025
8 companies · $943 in 2025
The $943 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,890 · 2023: $2,847 · 2024: $3,937 · 2025: $943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,181 · Travel and Lodging: $3,546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,181.22 |
| Travel and Lodging | $3,545.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,940.83 | 2022-2025 | Mako, Triathlon, Gmrs |
| Medwest Associates | $1,435.87 | 2022-2023 | |
| Depuy Synthes Sales INC. | $677.33 | 2024-2025 | Actis, Na, Inhance |
| Zimmer Biomet Holdings, INC. | $245.33 | 2025 | Activbraid, G7, Persona |
| Bioventus LLC | $162.03 | 2024 | Exogen Ultrasound Bone Healing System, Durolane |
| Medical Device Business Services, INC. | $110.00 | 2025 | Attune |
| Sanofi-Aventis U.S. LLC | $29.18 | 2023 | |
| Ferring Pharmaceuticals INC. | $16.82 | 2024 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hunter Aronson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.